We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $71.3B
1-Year Est. Return 56.8%
This Fund
S&P 500
This Quarter Est. Return
+24.89%
1 Year Est. Return
+56.8%
3 Year Est. Return
+170.28%
5 Year Est. Return
+249.16%
10 Year Est. Return
+1,007.9%
AUM
$71.3B
AUM Growth
+$6.48B
Cap. Flow
-$2.43B
Cap. Flow %
-3.41%
Top 10 Hldgs %
29.48%
Holding
1,130
New
174
Increased
291
Reduced
392
Closed
128

Top Buys

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$353M
2
MRVL icon
Marvell Technology
MRVL
+$150M
3
SYRE icon
Spyre Therapeutics
SYRE
+$126M
4
BBIO icon
BridgeBio Pharma
BBIO
+$116M
5
DOV icon
Dover
DOV
+$110M

Top Sells

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$713M
2
CNTA
Centessa Pharmaceuticals
CNTA
+$355M
3
CTRA
Coterra Energy
CTRA
+$289M
4
RPRX icon
Royalty Pharma
RPRX
+$259M
5
LLY icon
Eli Lilly
LLY
+$236M

Sector Composition

Rank Sector Weight
1 Technology 32.29%
2 Healthcare 14.03%
3 Financials 12.39%
4 Industrials 8.94%
5 Communication Services 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNP icon
826
CenterPoint Energy
CNP
$26.2B
$4.14M 0.01%
94,038
-443,800
-83% -$19M
PRLD icon
827
Prelude Therapeutics
PRLD
$406M
$4.08M 0.01%
+766,095
New +$3.33M
GPCR icon
828
Structure Therapeutics
GPCR
$2.94B
$4.03M 0.01%
+75,000
New +$3.32M
BF.B icon
829
Brown-Forman Class B
BF.B
$12B
$4M 0.01%
150,032
-2,400
-2% -$64.7K
BKD icon
830
Brookdale Senior Living
BKD
$2.9B
$3.85M 0.01%
239,000
-471,000
-66% -$6.4M
EXPD icon
831
Expeditors International
EXPD
$24.5B
$3.84M 0.01%
23,564
-14,058
-37% -$2.17M
PVLA
832
Palvella Therapeutics
PVLA
$2.18B
$3.82M 0.01%
25,000
– –
NHI icon
833
National Health Investors
NHI
$3.45B
$3.81M 0.01%
50,000
-110,000
-69% -$8.42M
TSHA icon
834
Taysha Gene Therapies
TSHA
$1.74B
$3.77M 0.01%
+553,000
New +$3.27M
ABVX
835
Abivax
ABVX
$10.4B
$3.53M 0.01%
26,500
-374,039
-93% -$42.3M
PZZA icon
836
Papa John's
PZZA
$712M
$3.43M ﹤0.01%
93,267
-69,033
-43% -$2.38M
NXDR
837
Nextdoor Holdings
NXDR
$832M
$3.4M ﹤0.01%
1,500,000
– –
DYN icon
838
Dyne Therapeutics
DYN
$3.58B
$3.33M ﹤0.01%
150,000
-850,000
-85% -$15.8M
JKHY icon
839
Jack Henry & Associates
JKHY
$11.1B
$3.21M ﹤0.01%
+23,286
New +$3.3M
MOG.A icon
840
Moog Inc Class A
MOG.A
$11.6B
$3.2M ﹤0.01%
7,553
– –
IVVD icon
841
Invivyd
IVVD
$235M
$3.19M ﹤0.01%
3,661,480
– –
PMVP icon
842
PMV Pharmaceuticals
PMVP
$73.5M
$3.16M ﹤0.01%
2,360,000
+500,000
+27% +$642K
CHRW icon
843
C.H. Robinson
CHRW
$17.6B
$3.1M ﹤0.01%
16,468
-64,826
-80% -$11.5M
JLL icon
844
Jones Lang LaSalle
JLL
$15.9B
$3.1M ﹤0.01%
10,000
+5,000
+100% +$1.55M
BBOT
845
BridgeBio Oncology
BBOT
$541M
$3.05M ﹤0.01%
400,000
– –
CLDT
846
Chatham Lodging
CLDT
$601M
$3.04M ﹤0.01%
230,000
-122,973
-35% -$1.27M
NWS icon
847
News Corp Class B
NWS
$17.7B
$3.01M ﹤0.01%
107,334
-1,700
-2% -$50.5K
WWD icon
848
Woodward
WWD
$19.9B
$2.94M ﹤0.01%
6,914
-20,074
-74% -$7.61M
ZVRA icon
849
Zevra Therapeutics
ZVRA
$715M
$2.87M ﹤0.01%
200,000
– –
ATRC icon
850
AtriCure
ATRC
$2.7B
$2.8M ﹤0.01%
100,000
-50,000
-33% -$1.41M
32 33
34
35 36

Similar funds

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $72.2B AUM 27.85% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $70.2B AUM 30.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

Adage Capital Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Adage Capital Partners held 1,130 positions worth $71.3B, up 10% from $64.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Adage Capital Partners withdrew a net $2.43B in Q2 2026, closing 128 positions and reducing 392 holdings. Its most notable exit was Centessa Pharmaceuticals, an estimated $355M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Adage Capital Partners opened a new position in Marvell Technology worth $222M.

  • Adage Capital Partners's largest Q2 2026 buy was Marvell Technology: 745,800 shares worth $222M.
  • Adage Capital Partners added most to Devon Energy in Q2 2026, an estimated $353M increase.
  • Adage Capital Partners's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $713M.
  • Adage Capital Partners fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $355M.
  • Adage Capital Partners's ten largest holdings make up 29% of its $71.3B portfolio in Q2 2026.
  • Adage Capital Partners opened 174 new positions and closed 128 in Q2 2026.
  • Adage Capital Partners's portfolio value rose 10% quarter-over-quarter to $71.3B.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.